Abstract:New Findings What is the central question of this study? Butyrate can prevent diet‐induced obesity through increasing energy expenditure. However, it is unclear whether β3‐adrenergic receptors (ARβ3) mediate butyrate‐induced adipose lipolysis. What is the main finding and its importance? Short‐term oral administration of sodium butyrate is effective in alleviating diet‐induced obesity through activation of ARβ3‐mediated lipolysis in white adipose tissue. Butyrate can prevent diet‐induced obesity through increasing energy expenditure. However, it is unclear whether ARβ3 mediates butyrate‐induced adipose lipolysis. In this study, weaned mice were were fed control (Con) or high‐fat (HF) diet for 8 weeks to establish obesity. High‐fat diet‐induced obese mice maintained on the HF diet were divided into two subgroups; the HFB group was gavaged with 80 mg sodium butyrate (SB) per mouse every other day for 10 days, whereas the HF group received vehicle. Chromatin immunoprecipitation assay was performed to determine the status of histone H3 lysine 9 acetylation (H3K9Ac) on the promoter of the β3‐adrenergic receptor (ARβ3) gene in epididymal white adipose tissue. It was shown that five gavage doses of SB significantly alleviated HF diet‐induced obesity and restored plasma leptin concentration to the control level. Protein contents of ARβ3 and PKA, as well as ATGL and p‐HSL (Ser563), were significantly upregulated in the HFB group compared with the HF group. Mitochondrial oxidative phosphorylation was enhanced by SB treatment. Sodium butyrate significantly increased the expression of four out of 13 mitochondrial DNA‐encoded genes and significantly upregulated the protein contents of peroxisome proliferator‐activated receptor‐γ coactivator 1α and COX4. Moreover, SB administration enhanced the expression of ARβ3 and its downstream signalling. The G protein‐coupled receptor 43 and p‐CREB (Ser133) were significantly stimulated by SB. In addition, an active transcription marker, H3K9Ac, was significantly enriched on the promoter of the ARβ3 gene. Our results indicate that short‐term oral administration of SB is effective in alleviating diet‐induced obesity through activation of the ARβ3‐mediated lipolysis in the epididymal white adipose tissue.

Different Short-Chain Fatty Acids Unequally Modulate Intestinal Homeostasis and Reverse Obesity-Related Symptoms in Lead-Exposed High-Fat Diet Mice

Butyric-lauric Acid Structural Lipid Relieves Liver Inflammation and Small Intestinal Microbial Disturbance: in Obese Male C57BL/6 Mice

Supplementation With Sodium Butyrate Modulates The Composition Of The Gut Microbiota And Ameliorates High-Fat Diet-Induced Obesity In Mice

Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota

Lead exposure exacerbates adverse effects of HFD on metabolic function via disruption of gut microbiome, leading to compromised barrier function and inflammation

Lead exposure exacerbates liver injury in high-fat diet-fed mice by disrupting the gut microbiota and related metabolites

Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms

Co-exposure to lead and high-fat diet aggravates systemic inflammation in mice by altering gut microbiota and the LPS/TLR4 Pathway

Sciadonic acid attenuates high-fat diet-induced obesity in mice with alterations in the gut microbiota

Lactiplantibacillus Plantarum P101 Alleviated Lead-Induced More Severe Hepatic Injury in Obese Mice, by Promoting Fecal Lead Excretion and Enhancing Antioxidative Defense System.

Sodium Acetate, Propionate, and Butyrate Reduce Fat Accumulation in Mice Via Modulating Appetite and Relevant Genes

Effect of exercise and butyrate supplementation on microbiota composition and lipid metabolism.

Butyrate-producing bacteria as probiotic supplement: beneficial effects on metabolism and modulation of behaviour in an obesity mouse model

Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice

Butyrate Stimulates Adipose Lipolysis and Mitochondrial Oxidative Phosphorylation Through Histone Hyperacetylation‐associated Β3‐adrenergic Receptor Activation in High‐fat Diet‐induced Obese Mice

Dietary butyrate ameliorates metabolic health associated with selective proliferation of gut Lachnospiraceae bacterium 28-4

Butyrate Alleviates High Fat Diet-Induced Obesity Through Activation of Adiponectin-Mediated Pathway and Stimulation of Mitochondrial Function in the Skeletal Muscle of Mice

Butyrate Alleviates High Fat Diet-induced Obesity Through Enhancement of Mitochondrial Function in The Liver of Mice

Bacillus amyloliquefaciens SC06 Protects Mice Against High-Fat Diet-Induced Obesity and Liver Injury via Regulating Host Metabolism and Gut Microbiota

Butyrate Alleviates Cognitive Impairment by Improving Gut Mucosal Barrier Function and Blocking Neuroinflammatory Signaling in LDLR-/- Mice

Microbiota-gut-adipose axis: butyrate-mediated the improvement effect on inflammatory response and fatty acid oxidation dysregulation attenuates obesity in sleep-restricted mice